2012.05.11
Differences Between Consolidated Forecasts and Consolidated Results for the Fiscal Year Ended March 31, 2012
HTML
PDF
2012.05.11
Daiichi Sankyo Announces New Executive Candidates
HTML
PDF
2012.05.11
Ranbaxy sales grew over 55% with improvement in base business profitability
HTML
PDF
2012.05.08
Daiichi Sankyo and Coherus Biosciences Establish Strategic Collaboration to Develop and Commercialize Biosimilar Candidates
HTML
PDF
2012.04.26
RANBAXY LAUNCHES SYNRIAM(TM) – INDIA’S FIRST NEW DRUG
HTML
PDF
2012.05.14
Archive Meeting Material for Top Management Presentation / Financial Results for Fiscal 2011
2012.05.11
Announcement of Financial Results for Fiscal 2011
2012.02.21
DAIICHI SANKYO Group Social Contribution Activities Report 2011 was published.
2012.01.31
Announcement of Financial Results for the 3Q of Fiscal 2011
2011.12.12
Daiichi Sankyo's CSR information now available on our website
2012.04.17
Daiichi Sankyo Launches RANMARK(R), a Treatment for Bone Complications Stemming from Multiple Myeloma and Bone Metastases from Solid Tumors
HTML
PDF
2012.03.23
Daiichi Sankyo Files for Approval in Japan to Market AMG 162 (denosumab), a Treatment for Osteoporosis
HTML
PDF
2012.03.23
Daiichi Sankyo to Develop Narcotic Analgesic Hydromorphone Hydrochloride in Japan
HTML
PDF
